Is it Safe for Patients With Cardiovascular Disease to Discontinue Low-Dose Aspirin Therapy?

In patients with cardiovascular disease, discontinuing low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events almost 7-fold, according to the January issue of Clinical Gastroenterology and Hepatology.

Many patients with cardiovascular disease receive low-dose aspirin, for its cardioprotective effects. However, aspirin can also cause or aggravate peptic ulcers. Clinicians must therefore carefully balance the cardioprotective and ulcerogenic properties of aspirin.

To determine whether patients with cardiovascular disease could safely stop taking aspirin when they develop ulcers, Maryam Derogar et al. analyzed data from patients treated with low-dose aspirin therapy at the Karolinska University Hospital (Stockholm, Sweden), and followed up to see what happened to those who developed bleeding peptic ulcers from 2007 to 2010.

They found that of the 118 patients who received low-dose aspirin therapy, this treatment was discontinued for 47 (40%).

After adjusting for confounding factors, patients with cardiovascular disease who discontinued low-dose aspirin therapy had an almost 7-fold increase in risk for death or acute cardiovascular events during the first 6 months of the follow-up period (see below figure).

Effects of aspirin discontinuation on survival, over 5 years

Effects of aspirin discontinuation on survival, over 4 years

The risk of death did not increase among patients without cardiovascular disease when the study began.

The findings led Derogar et al. to recommend that all patients with cardiovascular disease continue aspirin therapy, and take acid suppressants (such as proton pump inhibitors), to prevent gastrointestinal bleeding.

They state that aspirin reduces the risk of cardiovascular events in patients with cardiovascular disease at the expense of a small increase in gastrointestinal bleeding complications. However, the role of aspirin therapy in primary prevention of cardiovascular events is unclear. Because of the older age of the study population, overall mortality was high, which was expected—no patient younger than 64 years died or developed an acute cardiovascular event during the follow-up period. The results are therefore not fully applicable to younger patients; elderly people might be more susceptible to discontinuation of aspirin therapy.

More Information on Gastrointestinal Bleeding:

Read the article online.
Derogar M, Sandblom G, Lundell L, et al. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol 2013;11:38-42.

About these ads

About Kristine Novak, PhD, Science Editor

Dr. Kristine Novak is the science editor for Gastroenterology and Clinical Gastroenterology and Hepatology, both published by the American Gastroenterological Association. She has worked as an editor at biomedical research journals and as a science writer for more than 12 years, covering advances in gastroenterology, hepatology, cancer, immunology, biotechnology, molecular genetics, and clinical trials. She has a PhD in cell biology and an interest in all areas of medical research.
This entry was posted in GI Tract and tagged , , , , , , , , , . Bookmark the permalink.

6 Responses to Is it Safe for Patients With Cardiovascular Disease to Discontinue Low-Dose Aspirin Therapy?

  1. This is an important article and the results are not unexpected. However, it is unclear to me as to how many patients who were not prescribed aspirin on discharge, were restarted soon after during follow-up appointments vs never begun back on aspirin. Also, how soon after the patient had GI bleeding stopped, was the aspirin started. It is unclear how long patients were in the hospital before aspirin analysis on discharge.

  2. Thanks on your marvelous posting! I really
    enjoyed reading it, you will be a great author. I will ensure that I
    bookmark your blog and will come back later in life.
    I want to encourage you continue your great work, have a nice day!

  3. Pingback: Most Popular Gastroenterology and CGH Papers from 2013 |

  4. Pingback: Most Popular Gastroenterology and CGH Papers from 2013 | MiCasa Theme

  5. Pingback: Is it Safe for Patients With Cardiovascular Disease to Discontinue Low-Dose Aspirin Therapy? | 消化醫學衞教網站

  6. Pingback: Most Popular Gastroenterology and CGH Papers from 2013 | Heartburn Hub

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s